Lights, camera, ACTION!🎞️ Some behind-the-scenes shots of our expert panel from last night's discussion in Barcelona. A huge thank you to Neil Spooner, Aihua Liu, Zamas Lam, Dominic Warrino and Luca Ferrari for joining us! Registration for this event will be opening soon so stay tuned...🎥
Bioanalysis Zone
Book and Periodical Publishing
The definitive resource for the modern bioanalyst, featuring the latest news, research, webinars, eBooks and more
About us
Bioanalysis is a progressive discipline for which the future holds many exciting opportunities to further reduce sample volumes, analysis cost and environmental impact, as well as to improve sensitivity, specificity, accuracy, efficiency, assay throughput, data quality, data handling and processing. The journal Bioanalysis is a MEDLINE-indexed journal, focusing on the techniques and methods used for the detection or quantitative study of analytes in human or animal biological samples. The content is uniquely targeted to those working on the bioanalysis of drugs, metabolites and endogenous substances in biological matrices. The articles will also have wide appeal to analytical chemists, pharmacologists, clinical chemists, and those involved with metabolomics studies. The journal encourages the submission of articles describing forward-looking applications, including biosensors, microfluidics, miniaturized analytical devices, and new hyphenated and multi-dimensional techniques. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for the modern bioanalyst. Bioanalysis Zone provides bioanalysts with a range of resources, including: the latest news, research, reviews, interviews, informative webinars, eBooks, Spotlights focusing on bioanalytical ‘hot topics’, a business directory and more! On this page, we hope to provide a forum for the community to discuss recent developments and pose any questions related to this fast-moving field. https://www.bioanalysis-zone.com/
- Website
-
http://www.bioanalysis-zone.com
External link for Bioanalysis Zone
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- London
- Type
- Public Company
- Specialties
- Bioanalysis, Chromatography, Biomarkers, Microsampling, MS, Immunogenicity, LBA, Webinars, Clinical, Biosimilars, Oligonucleotides, Biopharmaceuticals, Bioanalysis Rising Star Award, Bioanalysis Outstanding Contribution Award, Drug development, Spotlights, Ask the Experts, In the Zone, Panel discussions, Interviews, and Research
Locations
-
Primary
Get directions
2 Albert Place
London, N3 1QB, GB
Updates
-
What do you find most inspiring about your work as a bioanalytical scientist? Watch our video interview with our 2024 Bioanalysis Rising Star Award winner now 🌟🏆>>> https://hubs.ly/Q02-Vb6g0
-
Svar Life Science AB is a GxP-certified bioanalytical CRO focusing on various bioassay services – both ligand binding and cell-based. Find out more about what they could do for you on their company profile. Check it out >>> https://hubs.ly/Q02VSYyZ0
SVAR Life Science
-
We caught up with Piet Van Der Graaf from Certara about his Closing Plenary on AI and AI-assisted approaches in pharmaceutical discovery and development. Watch the filmed interview now! >>> https://lnkd.in/egYm6eur
-
-
Want to learn more about flow cytometry clinical trials? Look no further and register for our on-demand Panel discussion with experts, @YanmeiLu, @Tong-YuanYang, @ ! >>> https://hubs.ly/Q02-lMXJ0
Challenges and opportunities for high-complexity flow cytometry in clinical trials
-
There is a growing demand for detailed analysis of AAVs to understand their safety profiles and their broader applications across different therapeutic areas. Our Spotlight in partnership with Charles River Laboratories will highlight the significant contributions of bioanalytical methods to the development and assessment of AAV therapies. Check it out >>> https://hubs.ly/Q02TYNb90
-
-
We know you love an eBook... Our latest one, ‘The current bioanalytical landscape for biosimilars’, in collaboration with PPD is now available to download! Get it now >>> https://hubs.ly/Q02ZvXGy0
eBook: The current bioanalytical landscape for biosimilars
-
Read this article, which aimed to compare ADA interference in four PK assays across different platforms (AlphaLISA, Gyrolab, LC-MS/MS) and to devise a strategy for ADA interference mitigation to improve the accuracy of measured drug in total PK assays: https://hubs.ly/Q02-V9z-0
Interference from anti-drug antibodies on the quantification of insulin: a comparison of an LC-MS/MS assay and immunoassays
-
From regulatory compliance to technological advancements, our panelists delved into the challenges and advances in AAV therapy bioanalysis. Gain insight from experts at Charles River Laboratories, Sangam Therapeutics and Johnson & Johnson Innovative Medicine in this Panel discussion. Now available on demand! >>> https://hubs.ly/Q02XyjNy0
-
-
Find out more about the evolving precision medicine landscape and therapeutic options in breast cancer in Labcorp’s case study. Download that case study and others through their company profile on Bioanalysis Zone >>> https://hubs.ly/Q02VT5V30
-